Alan Yagoda - Concepedia

Author

Alan Yagoda

Memorial Sloan Kettering Cancer Center

Also Known As

A Yagoda, A. YAGODA, A. Yagoda, ALAN YAGODA, Alan Yagoda, Andreas P. Kyriazis, Darius Unwala, Jindra Windrichova

128

Publications

8.1K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University North Shore University Hospital

About

Alan Yagoda is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	52	2.9K
2	Health Sciences	6	6	420
3	Cell Biology	2	2	32
4	Natural Sciences	1	1	28
5	Biochemistry	1	1	28

Alan Yagoda

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium Janice Gabrilove, Ann A. Jakubowski, Howard I. Scher, New England Journal of Medicine	1988	953
Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse Cora N. Sternberg, Alan Yagoda, Howard I. Scher, Cancer	1989	673
Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium Cora N. Sternberg, Alan Yagoda, Howard I. Scher, The Journal of Urology	1985	659
M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Advanced Transitional Cell Carcinoma of the Urothelium Cora N. Sternberg, Alan Yagoda, Howard I. Scher, The Journal of Urology	1988	627
Bleomycin, an Antitumor Antibiotic Alan Yagoda Annals of Internal Medicine Surgical OncologyPathologyPharmacotherapyAntimicrobial ChemotherapyDrug Resistance	1972	292
A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors. George J. Bosl, Nancy L. Geller, Dean F. Bajorin, Journal of Clinical Oncology Disseminated GctSurgical OncologyGenitourinary CancerMedicineStandard Chemotherapy	1988	253
Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium. Janice Gabrilove, Ann A. Jakubowski, Katie Fain, Journal of Clinical Investigation ImmunologyBlood CellPathologyImmunotherapyInflammation	1988	231
Neoadjuvant M-Vac (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) Effect on the Primary Bladder Lesion Howard I. Scher, Alan Yagoda, Harry W. Herr, The Journal of Urology	1988	214
CYTOTOXIC CHEMOTHERAPY FOR ADVANCED RENAL CELL CARCINOMA Alan Yagoda, Daniel P. Petrylak, Seth Thompson Urologic Clinics of North America OncologyUrologyMedicineGenitourinary Cancer	1993	206
Cis-dichlorodiammineplatinum(II) in advanced bladder cancer. Alan Yagoda, Watson Rc, Gonzalez-Vitale Jc, PubMed UrologyAdvanced Bladder CancerGenitourinary CancerMedicinePharmacology	1976	143

Page 1